National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Cognitive Disorders and Delirium (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 09/09/2008



Purpose of This PDQ Summary






Definitions and Epidemiology






Etiology of Cognitive Disorders and Delirium






Impact of Cognitive Disorders and Delirium on Patient, Family, and Healthcare Personnel






Diagnosis and Monitoring






General Management Approach to Delirium






Get More Information From NCI






Changes to This Summary (09/09/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Impact of Cognitive Disorders and Delirium on Patient, Family, and Healthcare Personnel

The clinical presentation of cognitive disorders and delirium is associated with a high level of distress in patients, family members, and health care personnel.[1,2] Delirium is associated with a high burden of symptom distress, particularly in relation to delusions, perceptual disturbances, and psychomotor agitation. Incontinence, falls, failure to maintain adequate hydration, a prolonged hospital stay, and death are more likely to occur in the patient with delirium.[3-9] Dysfunctional cognition in the delirious patient hinders communication between patient and family and between patient and health care personnel. As a result, reliable symptom assessment, counseling, and active patient participation in the therapeutic decision-making process are all compromised.[10] Psychomotor agitation and emotional lability in the delirious patient may be misinterpreted as a presentation of increased pain expression.[11] Consequently, conflict can arise among the patient, family, and staff concerning the level of analgesia needed. A potentially destructive triangle can develop when the patient’s family misinterprets agitation as increased pain and advocates for inappropriate escalation of opioid dosing.[12] A psychosocial intervention for family caregivers of patients with advanced cancer may be beneficial in providing knowledge of delirium and detection rates and in increasing family caregiver self-confidence in decision making.[13]

References

  1. Breitbart W, Gibson C, Tremblay A: The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43 (3): 183-94, 2002 May-Jun.  [PUBMED Abstract]

  2. Morita T, Hirai K, Sakaguchi Y, et al.: Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics 45 (2): 107-13, 2004 Mar-Apr.  [PUBMED Abstract]

  3. Lawlor PG, Gagnon B, Mancini IL, et al.: Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160 (6): 786-94, 2000.  [PUBMED Abstract]

  4. Bruera E, Miller L, McCallion J, et al.: Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7 (4): 192-5, 1992.  [PUBMED Abstract]

  5. Hogan DB: Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients. CMAJ 157 (8): 1071-7, 1997.  [PUBMED Abstract]

  6. O'Keeffe ST, Lavan JN: Clinical significance of delirium subtypes in older people. Age Ageing 28 (2): 115-9, 1999.  [PUBMED Abstract]

  7. Lawlor PG: Delirium and dehydration: some fluid for thought? Support Care Cancer 10 (6): 445-54, 2002.  [PUBMED Abstract]

  8. O'Keeffe S, Lavan J: The prognostic significance of delirium in older hospital patients. J Am Geriatr Soc 45 (2): 174-8, 1997.  [PUBMED Abstract]

  9. Caraceni A, Nanni O, Maltoni M, et al.: Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 89 (5): 1145-9, 2000.  [PUBMED Abstract]

  10. Lawlor PG, Fainsinger RL, Bruera ED: Delirium at the end of life: critical issues in clinical practice and research. JAMA 284 (19): 2427-9, 2000.  [PUBMED Abstract]

  11. Gagnon B, Lawlor PG, Mancini IL, et al.: The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patients. J Pain Symptom Manage 22 (4): 826-33, 2001.  [PUBMED Abstract]

  12. Fainsinger RL, Tapper M, Bruera E: A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 9 (3): 4-8, 1993 Autumn.  [PUBMED Abstract]

  13. Gagnon P, Charbonneau C, Allard P, et al.: Delirium in advanced cancer: a psychoeducational intervention for family caregivers. J Palliat Care 18 (4): 253-61, 2002 Winter.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov